삼성서울병원

Ko En

유방외과분과 유재민 교수

진료분야
유방암, 유방로봇수술, 유전성유방암난소암증후군
진료일정 03 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2019.08 성균관대학교 의과대학원 의학 박사 졸업
2016.08 성균관대학교 의과대학원 의학 석사 졸업
2007.02 영남대학교 의학과 졸업

경력

경력
2023.03 ~현재 성균관대학교 의과대학 외과학교실 부교수
2022.03 ~현재 삼성서울병원 부교수
2018.03 ~현재 삼성서울병원 기관윤리사무국 위원회 (IRB) 위원
2020.03 ~ 2022.02 삼성서울병원 진료조교수
2018.03 ~ 2020.02 삼성서울병원 임상조교수
2015.05 ~ 2018.02 삼성서울병원 임상강사
2012.04 ~ 2015.05 군의관
2008.03 ~ 2012.02 삼성서울병원 전공의
2007.03 ~ 2008.02 영남대병원 인턴

학회활동

학회활동
2021.09 ~ 현재 한국로봇내시경최소침습 유방 수술연구회 학술위원
2021.04 ~ 현재 한국유방암학회 국제위원회 간사
2020.03 ~ 현재 한국 유방암학회 학술위원회 간사
2019.06 ~ 현재 한국 유방암학회 임상시험위원회 위원
2019.05 ~ 현재 한국 유방암학회 교육위원회 위원
2019.05 ~ 현재 한국 유방암학회 국제 위원회 위원
2019.05 ~ 현재 한국 유방암학회 국제위원회 위원
2019.05 ~ 현재 한국 유방암학회 학술위원회 위원
2018.06 ~ 현재 대한 림프부종학회 정회원
2018.06 ~ 현재 대한 종양외과학회 재무위원회 위원
2018.06 ~ 현재 한국 유방암학회 진료권고안위원회 위원(유전성 유방암)
2015.01 ~ 현재 한국 유방암학회 정회원
2012.01 ~ 현재 대한 외과학회 회원
2020.03 ~ 2021.04 한국유방암학회 학술위원회 간사

수상이력

수상이력
2021.04 Young investigator award (젊은 의학자상, 한국유방암학회)
2019.03 Global Poster Presentation (미국 종양외과학회)
2019.02 Best oral presentation (우수 구연자상, 대한종양외과학회
2018.04 Young investigator award (젊은 의학자상, 한국 유방암학회)
2018.02 Best oral presentation (우수 구연자상, 대한 종양외과학회)
2017.05 Young investigator award (젊은 의학자상, 대한 외과학회)
2016.11 Best investigator award (우수 의학자상, 대한 외과학회)
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • J CLIN ONCOL 2023 10.1200/JCO.23.00557 Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial Baek, SY; Noh, WC; Ahn, SH; Kim, HA; Ryu, JM; Kim, SI; Lee, EG; Im, SA; Jung, YS; Park, MH; Park, KH; Kang, SH; Jeong, J; Park, E; Kim, SY; Lee, MH; Kim, LS; Lim, W; Kim, S; Kim, HJ
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15184485 Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing Baroutsou, V; Duong, V; Signorini, A; Saccilotto, R; Ciorba, FM; Bürki, N; Caiata-Zufferey, M; Ryu, JM; Kim, SW; Lim, MC; Monnerat, C; Zürrer-Härdi, U; Kim, J; Heinimann, K; Graffeo, R; Park, JS; Rabaglio, M; Chappuis, PO; Kim, S; Katapodi, MC; CASCADE and K CASCADE Consortia
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BMC CANCER 2023 10.1186/s12885-023-10978-0 Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG) Ryu, JM; Lee, J; Lee, JY; Ko, BM; Kim, JH; Shin, H; Park, HS
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e17 Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e11 Impact of Adjuvant Hormone Therapy on Sleep, Physical Activity, and Quality of Life in Premenopausal Breast Cancer: 12-Month Observational Study Yeo, SM; Lim, JY; Kim, SW; Chae, BJ; Yu, JH; Ryu, JM; Hwang, JH
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.104.3.137 The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1039670 The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
    View PubMed
  • BRIT J SURG 2023 10.1093/bjs/znad006 Robot-assisted mastectomy: next major advance in breast cancer surgery Toesca, A; Park, HS; Ryu, JM; Kim, YJ; Lee, J; Sangalli, C; Maisonneuve, P; Marrazzo, E; Pozzi, G; Gazzetta, G; Montemurro, F; Corso, G; Lissidini, G; Caldarella, P; Mazzotta, E; Massari, G; Veronesi, P
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12389-0 Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • ANN SURG TREAT RES 2022 10.4174/astr.2022.103.6.323 Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant Bang, YJ; Kwon, WK; Kim, JW; Lee, JE; Jung, BY; Kim, M; Kim, J; An, J; Jung, SP; Kim, HK; Kim, Z; Youn, HJ; Ryu, JM; Kim, SW
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12602-0 ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter? Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-12075-1 ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • CANCER GENET-NY 2022 10.1016/j.cancergen.2022.05.042 Discovery of BRCA1/BRCA2 founder variants by haplotype analysis Kwon, WK; Jang, HJ; Lee, JE; Park, YH; Ryu, JM; Yu, J; Jang, JH; Kim, JW
    View PubMed
  • WORLD J SURG ONCOL 2022 10.1186/s12957-022-02673-4 Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis Cha, C; Kim, EY; Kim, SY; Ryu, JM; Park, MH; Lee, S; Suh, YJ; Choi, N; Hong, H; Kim, HS; Chung, MS
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11865-x Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A
    View PubMed
  • ANN SURG 2022 10.1097/SLA.0000000000004492 Robot-assisted Nipple-sparing Mastectomy With Immediate Breast Reconstruction An initial Experience of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) Ryu, JM; Kim, JY; Choi, HJ; Ko, B; Kim, J; Cho, J; Lee, MH; Choi, JE; Kim, JH; Lee, J; Jung, SM; Shin, HJ; Lee, J; Park, HS
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e17 Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE
    View PubMed
  • BMC CANCER 2022 10.1186/s12885-022-09273-1 No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial Jung, JG; Ahn, SH; Lee, S; Kim, EK; Ryu, JM; Park, S; Lim, W; Jung, YS; Chung, IY; Jeong, J; Chang, JH; Shin, KH; Chang, JM; Moon, WK; Han, W
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-00278-7 From cadaveric and animal studies to the clinical reality of robotic mastectomy: a feasibility report of training program Lee, J; Park, HS; Lee, DW; Song, SY; Yu, J; Ryu, JM; Bae, SJ; Lew, DH; Kim, SI; Toesca, A
    View PubMed
  • ANN SURG TREAT RES 2021 10.4174/astr.2021.101.3.131 Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories Kim, BK; Ryu, JM; Oh, SJ; Han, J; Choi, JE; Jeong, J; Suh, YJ; Lee, J; Sun, WY
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-96855-x Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients Cho, SY; Lee, JH; Ryu, JM; Lee, JE; Cho, EY; Ahn, CH; Paeng, K; Yoo, I; Ock, CY; Song, SY
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e194 Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277 Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e16 Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations Alyami1, H; Yoo, TK; Cheun, JH; Lee, HB; Jung, SM; Ryu, JM; Bae, SJ; Jeong, J; Yoon, CI; Ahn, J; Paik, PS; Cho, MK; Park, WC
    View PubMed
  • BMC SURG 2021 10.1186/s12893-021-01129-y The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e4 Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.588728 Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer Kwon1, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE
    View PubMed
  • EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023 Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-020-07729-w Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander? Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
    View PubMed
  • Japanese journal of clinical oncology./2020.02 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Jai Min Ryu 1 1, Seok Jin Nam 1 , Seok Won Kim 1 , Jeong Eon Lee 1 , Byung Joo Chae 1 , Se Kyung Lee 1 , Jonghan Yu 1
  • Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant /2020.07.31 Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant Hyung Seok Park 1 1, Jai Min Ryu 2 , Ji Soo Park 3 , Seock-Ah Im 4 5 , So-Youn Jung 6 , Eun-Kyu Kim 7 8 , Woo-Chan Park 9 , Jun Won Min 10 , Jeeyeon Lee 11 , Ji Young You 12 , Jeong Eon Lee 2 , Sung-Won Kim 13
  • JAMA SURG 2020 10.1001/jamasurg.2020.4124 Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence Lee1, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e61 Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation Jung1, SM; Ryu, JM; Park, HS; Park, JS; Kang, E; Lee, S; Lee, HB; Youn, HJ; Yoo, TK; Kim, J; Lee, JE; Han, SA; Kim, D; Kim, SW
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251 Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer? Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05952-4 Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women Park1, JW; Han, KD; Shin, DW; Yeo, Y; Chang, JW; Yoo, JE; Jeong, SM; Lee, SK; Ryu, JM; Park, YM
    View PubMed
  • NUTRIENTS 2020 10.3390/nu12092831 Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients Kim1, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.351 Clinicopathological Features of Patients with the BRCA1 c.5339T > C (p.Leu1780Pro) Variant Park1, HS; Ryu, JM; Park, JS; Im, SA; Jung, SY; Kim, EK; Park, WC; Min, JW; Lee, J; You, JY; Lee, JE; Kim, SW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041192 Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
    View PubMed
  • ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169 Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
    View PubMed
  • EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011 A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • NUTRIENTS 2019 10.3390/nu11010037 Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
    View PubMed
  • Breast Cancer Res Treat./ 2018 Sep 14. Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer. Ryu JM1, Choi HJ, Kim I, Lee SK, Yu J, Kim JE, Kang BI, Lee JE, Nam SJ, Kim SW.
  • Breast Cancer Res Treat. /2018 Oct 22 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu JM1, Choi HJ, Kim I, Nam SJ, Kim SW, Yu J, Lee SK, Choi DH, Park YH, Kim JW, Seo JS, Park JH, Lee JE, Kim SW
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e54 Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e50 Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.222 Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.173 Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4342-7 Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003 Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
    View PubMed
  • Breast/ 2017 Jun Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea Ryu JM1, Kang G, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Kim JW, Park SS, Lee JE, Kim SW.
  • Breast Cancer Res Treat/. 2017 Dec Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society Ryu JM1, Yu J, Kim SI, Kim KS, Moon HG, Choi JE, Jeong J, Do Byun K, Nam SJ, Lee JE, Lee SK, Kim SW.
  • Clin Breast Cancer 2017 Nov Predictive factors for nonsentinel lymph node metastasis in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Ryu JM1, SK Lee, JY Kim, HJ Paik, S Park, J Yu, SW Kim, JE Lee, SY, Bae, SW Han, YS Jung, SJ Nam
  • J Breast Cancer/2017 March Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study. Ryu JM1, Paik HJ, Park S, Yi HW, Nam SJ, Kim SW, Lee SK, Yu J, Bae SY, Lee JE.
  • Clin Breast Cancer 2017 June Oncologic safety of immediate breast reconstruction in breast cancer patients who underwent neoadjuvant chemotherapy: Short-term outcomes of a matched case control study. JM Ryu1, S Park, HJ Paik, SJ Nam, SW Kim, SK Lee, J Yu, SY Bae, I Kim, SI Bang, GH Mun, JK Pyon, BJ Jeon, JE Lee
  • Breast. 2016 Dec Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype. Alramadhan M1, Ryu JM, Rayzah M, Nam SJ, Kim SW, Yu J, Lee SK, Bae SY, Park S, Paik HJ, Lee JE
  • Breast Cancer Res Treat /2017 Feb Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society. Ryu JM1, HJ Lee, TI Yoon, ES Lee, SJ Lee, JH Jung, BJ Chae, SJ Nam, JE Lee, SK Lee, SY Bae, J Yu, SW Kim
  • World J Surg. 2016 Aug Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm. Ryu JM1, Nam SJ, Kim SW, Lee SK, Bae SY, Yi HW, Park S, Paik HJ, Lee JE.